Becton, Dickinson and Co. | Actif À Court Terme



Current Assets Changement Date
Abbott USD 23.15B 503M 2025-03
Agilent USD 4.11B 148M 2025-01
Align Technology USD 2.4B 90.41M 2025-03
Avanos Medical USD 393.4M 79.2M 2024-12
Baxter International USD 8.85B 11M 2024-12
Becton, Dickinson and Co. USD 8.66B 1.81B 2024-12
Bio-Rad Laboratories USD 3.03B 25.32M 2024-12
Boston Scientific USD 6.92B 1.84B 2024-12
Cooper Companies USD 1.99B 35.5M 2025-01
Danaher USD 9.52B 28M 2025-03
Dentsply International USD 1.75B 175M 2024-12
Dexcom USD 4.3B 38.6M 2024-12
Edwards Lifesciences USD 6.29B 442.3M 2024-12
Exact Sciences USD 1.57B 38.31M 2024-12
Globus Medical USD 2.18B 120.73M 2024-12
Hologic USD 3.49B 329.7M 2024-12
Insulet USD 1.89B 30.4M 2024-12
Integra LifeSciences USD 1.08B 17.84M 2024-12
Intuitive Surgical USD 11.88B 331.3M 2025-03
J&J USD 71.55B 15.66B 2025-03
Masimo USD 1.23B 54.1M 2024-12
Medtronic USD 22.51B 75M 2025-01
Solventum Corp 3.25B 105M 2024-12
Stryker USD 14.85B 174M 2024-12
Tandem Diabetes Care USD 663.44M 61.06M 2025-03
Teleflex USD 1.54B 67.79M 2025-03
Terumo JPY 735.97B 56.77B 2024-12
Thermo Fisher Scientific USD 23.38B 1.24B 2025-03
Zimmer Biomet Holdings USD 4.67B 192.5M 2024-12



Becton, Dickinson and Co. Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.